ST-Elevation Myocardial Infarction clinical trials at UCSF
1 research study open to eligible people
ST-elevation myocardial infarction happens when blood flow is blocked in a major heart artery. UCSF is running studies to find effective treatments for these heart attacks. Researchers are testing whether using guided tests or direct artery views helps in deciding patient care.
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
open to eligible people ages 18 years and up
COMPLETE-2 is a prospective, multi-centre, randomized controlled trial comparing a strategy of physiology-guided complete revascularization to angiography-guided complete revascularization in patients with acute ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel coronary artery disease (CAD) who have undergone successful culprit lesion Percutaneous Coronary Intervention (PCI). COMPLETE-2 OCT is a large scale, prospective, multi-centre, observational, imaging study of patients with STEMI or NSTEMI and multivessel CAD in a subset of eligible COMPLETE-2 patients.
San Francisco, California and other locations
Our lead scientists for ST-Elevation Myocardial Infarction research studies include Krishan Soni, MD.
Last updated: